Purple Biotech Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Purple Biotech Ltd. generated cash of -$19,226,000, which is less than the previous year. Cash used in financing activities reached the amount of $5,449,000 last year. Net change in cash is therefore -$541,000.
Cash Flow
| 2014 | -4.52M | 0 | 5.82M |
|---|---|---|---|
| 2015 | -3.30M | -9K | 12.63M |
| 2016 | -6.26M | -7.90M | 10.42M |
| 2017 | -8.62M | 2.77M | 2.99M |
| 2018 | -8.48M | 2.04M | 7.78M |
| 2019 | -5.58M | -449K | 5.23M |
| 2020 | -12.09M | -49.59M | 68.48M |
| 2021 | -15.07M | 13.40M | 1.51M |
| 2022 | -16.73M | 19.91M | 1.11M |
| 2023 | -19.22M | 13.88M | 5.44M |
PPBT Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 15.03M | 10.89M | 11.24M | 4.38M | 5.16M | 3.94M | 6.75M | 10.55M | 1.31M | 193K |
Operating activities | ||||||||||
Net income | -19.88M | -21.76M | -17.82M | -28.07M | -5.89M | -5.56M | -13.00M | -12.12M | -4.20M | -5.25M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 197K | 201K | 231K | 235K | 179K | 7K | 4K | 2K | 1K | 0 |
Stock-based compensation expense | 1.87M | 2.41M | 2.08M | 2.64M | 1.27M | 0 | 2.30M | 400K | 59K | 88K |
| Deferred income tax benefit | 1.87M | 2.41M | 2.08M | 2.64M | 1.27M | 0 | 2.30M | 400K | 59K | 88K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 178K | 313K | -316K | 501K | 62K | -1.11M | -273K | 0 | 197K | -375 |
Inventories | 0 | 0 | 573K | -511K | -62K | 0 | 0 | 0 | 54K | 0 |
Accounts payable | 1.33M | 799K | 266K | -2.33M | 503K | 393K | -491K | -138K | -152K | 453K |
Cash generated by operating activities | -19.22M | -16.73M | -15.07M | -12.09M | -5.58M | -8.48M | -8.62M | -6.26M | -3.30M | -4.52M |
Investing activities | ||||||||||
Purchases Of Investments | -17.43K | 0 | 0 | -49.61M | -2.1M | 0 | 0 | -7.89M | 0 | 0 |
Investments In Property Plant And Equipment | -2.99K | -228K | -115K | -156K | -11K | -16K | -13K | -10K | -9K | 0 |
Acquisitions Net | -3.54M | 0 | 0 | 69K | 0 | 0 | -1.73M | 0 | 0 | 0 |
Cash generated by investing activities | 13.88M | 19.91M | 13.40M | -49.59M | -449K | 2.04M | 2.77M | -7.90M | -9K | 0 |
Financing activities | ||||||||||
Common Stock Issued | 1.56M | 1.49M | 564K | 27.92M | 2.59M | 4.68M | 2.41M | 6.28M | 14.94M | 6.84M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -168K | -165K | -153K | -188K | -171K | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 5.44M | 1.11M | 1.51M | 68.48M | 5.23M | 7.78M | 2.99M | 10.42M | 12.63M | 5.82M |
Net Change In Cash | -541K | 4.14M | -357K | 6.86M | -778K | 1.21M | -2.81M | -3.8M | 9.24M | 1.12M |
Cash at end of period | 14.48M | 15.03M | 10.89M | 11.24M | 4.38M | 5.16M | 3.94M | 6.75M | 10.55M | 1.31M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |